US$ 28.22
nejm retatrutide 2024 Retatrutide (not yet approved in US but people using anyway) promises even potentially greater weight loss amongst the GLP1 drugs. https://www.nejm.org/doi/full/10.1056/NEJMoa2301972 Retatrutide (24mg Vial) Dosage Protocol
Description
Suraj Malhan, DO, headache and facial pain neurologist at RWJBarnabas Health, Monmouth Medical Center

Intended Use: Strictly for in-vitro laboratory research

Conclusion As we navigate the complexities of medications like Ozempic, understanding the potential side effectsincluding the less common experiences like chillsis crucial for informed decision-making

Therefore, it will be necessary for future work to examine GLP-1 users experiences of stigma in everyday life to quantify the frequency and intensity with which it is experienced

This is not a replacement for semaglutide
